As shown in Figure 3C, treatment with Iso at both concentrations results in a decrease in proteolytic activity, demonstrated by accumulation of MMP9 proteases in cancer cells, and also by decreased proteolytic fractions of 72 kDa (proMMP2) and active MMP2 (66 kDa). The gene discussed is MMP9; the disease is cancer.